Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of Two Potencies of Takeda's Tetravalent Dengue Vaccine in Adults
NCT02425098Phase 2Completed
- Sponsor
- Takeda
- Start
- Jun 2015
- Primary completion
- Sep 2017
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of dengue tetravalent vaccine (live, attenuated) in dengue fever, sponsored by Takeda. Started Jun 2015; status: completed.
02
Drugs
dengue tetravalent vaccine (live, attenuated)
03
Conditions
dengue fever
Beyond the preview
Go deeper on NCT02425098.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02425098.